Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Simon Latimer - Head of Investor Relations John Higgins - CEO Matt Foehr - COO Matt Korenberg - CFO Conference Call Participants Larry Solow - CJS Securities Matt Hewitt - Craig Hallum Capital Operator Good day, everyone. And welcome to the Ligand Pharmaceuticals First Quarter '22 Earnings Call. At this time, all participants are in a listen-only mode [Operator Instructions]. Please ...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2021 Earnings Conference Call February 17, 2022 4:30 PM ET | --- | |--------------------------------------------| | | | Company Participants | | Simon Latimer - Head of Investor Relations | | John Higgins - Chief Executive Officer | | Matt Korenberg - Chief Financial Officer | | Matt Foehr - Chief Operating Officer | | Conference Call Participants | | Joe Pantginis - H.C. Wainwright | | Larry Solow - CJS Securities | | Matt Hewitt - Craig-Hallum | | Jacob ...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Simon Latimer - Head of IR John Higgins - CEO Matthew Korenberg - CFO Matt Foehr - COO Conference Call Participants Lawrence Solow - CJS Securities Matt Hewitt - Craig Hallum Capital Group Jacob Johnson - Stephens Scott Henry - ROTH Capital Operator Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Third Quarter Earnings Call. At this time all partic ...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2021 Earnings Conference Call July 29, 2021 4:30 PM ET Company Participants Simon Latimer - Head of IR John Higgins - CEO Matthew Korenberg - CFO Matt Foehr - COO Matthew Foehr - Conference Call Participants Lawrence Solow - CJS Securities Matt Hewitt - Craig-Hallum Capital Balaji Prasad - Barclays Jacob Johnson - Stephens Scott Henry - ROTH Capital Operator Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Second Quarter Earni ...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2021 Earnings Conference Call May 3, 2021 2:30 PM ET Company Participants John Higgins - Chief Executive Officer Matthew Korenberg - Executive Vice President, Finance and Chief Financial Officer Matthew Foehr - President and Chief Operating Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright Lawrence Solow - CJS Securities Balaji Prasad - Barclays Matt Hewitt - Craig-Hallum Capital Scott Henry - ROTH Capital Dana Flanders - Guggenheim ...

Company Overview March - 2021 Nasdaq: LGND 1 Copyright © 2020 Ligand. All Rights Reserved. 2 SAFE HARBOR STATEMENT The following presentation contains forward-looking statements by Ligand and its partners that involve risks and uncertainties and reflect Ligand's and it's partners' judgment as of the date of this presentation. Words such as "plans," "believes," "expects," "projects," "could," "anticipates," and "will," and similar expressions, are intended to identify forward-looking statements. These forwar ...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2020 Earnings Conference Call February 3, 2021 8:30 AM ET Â Company Participants Patrick O'Brien - Investor Relations John Higgins - Chief Executive Officer Matt Korenberg - Executive Vice President, Finance and Chief Financial Officer Matt Foehr - President and Chief Operating Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Balaji Prasad - Barclays Matt Hewitt - Craig-Hallum Capital Group Scott Henry - Roth Capital Dana Flanders - Gu ...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2020 Earnings Conference Call October 30, 2020 8:30 AM ET Company Participants Patrick O'Brien - Investor Relations John Higgins - Chief Executive Officer Matt Korenberg - Executive Vice President, Finance & Chief Financial Officer Matt Foehr - President & Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Balaji Prasad - Barclays Joe Pantginis - H.C. Wainwright Scott Henry - Roth Capital Dana Flanders - Guggenhe ...

Q3 RESULTS AND FULL-YEAR 2020 OUTLOOK October 30, 2020 Nasdaq: LGND 2 SAFE HARBOR STATEMENT The following presentation contains forward-looking statements by Ligand that involve risks and uncertainties and reflect Ligand's judgment as of the date of this presentation. Words such as "plans," "believes," "expects," "could," and "will," and similar expressions, are intended to identify forward-looking statements. These forward-looking statements include, without limitation, financial projections, expectations ...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2020 Earnings Conference Call August 3, 2020 8:30 AM ET Company Participants Patrick O'Brien - Investor Relations John Higgins - Chief Executive Officer Matt Korenberg - Executive Vice President, Finance & Chief Financial Officer Matt Foehr - President & Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Joe Pantginis - H.C. Wainwright Balaji Prasad - Barclays Larry Solow - CJS Securities Scott Henry - Roth Capit ...